We are live on
!
Find out more
Lexicon Pharmaceuticals
LXRX
LXRX
126 hedge funds and large institutions have $940M invested in Lexicon Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 40 increasing their positions, 38 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
5% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 38
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1.64% less ownership
Funds ownership: 105.58% → 103.95% (-1.6%)
5% less funds holding
Funds holding: 133 → 126 (-7)
15% less capital invested
Capital invested by funds: $1.1B → $940M (-$162M)
40% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 15
66% less call options, than puts
Call options by funds: $450K | Put options by funds: $1.34M
Holders
126
Holders Change
-7
Holders Change %
-5.26%
% of All Funds
2.89%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
9
Increased
40
Reduced
38
Closed
15
Calls
$450K
Puts
$1.34M
Net Calls
-$893K
Net Calls Change
-$668K
Top Buyers
| 1 |
Marshall Wace
London,
United Kingdom
|
+$6.81M |
| 2 |
State Street
Boston,
Massachusetts
|
+$3.08M |
| 3 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$1.32M |
| 4 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
+$1.28M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$984K |
Top Sellers
| 1 |
VOYA Investment Management
Atlanta,
Georgia
|
-$9.65M |
| 2 |
UIM
USS Investment Management
London,
United Kingdom
|
-$7.08M |
| 3 |
Millennium Management
New York
|
-$3.77M |
| 4 |
Renaissance Technologies
New York
|
-$2.55M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$1.36M |
